{"id":"NCT00890981","sponsor":"Amgen","briefTitle":"A High-resolution Peripheral Quantitative Computed Tomography Study in Postmenopausal Women Previously Treated With Denosumab","officialTitle":"A HR-pQCT Study in Postmenopausal Women Previously Treated With Denosumab","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-07","primaryCompletion":"2010-06","completion":"2010-08","firstPosted":"2009-04-30","resultsPosted":"2011-07-28","lastUpdate":"2014-04-02"},"enrollment":79,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"SUPPORTIVE_CARE"},"conditions":["Low Bone Mass","Low Bone Mineral Density","Osteoporosis","Postmenopausal Osteoporosis"],"interventions":[{"type":"PROCEDURE","name":"high-resolution peripheral quantitative computed tomography (HR-pQCT)","otherNames":[]},{"type":"PROCEDURE","name":"Dual energy X-ray absorptiometry (DXA)","otherNames":[]},{"type":"BIOLOGICAL","name":"Denosumab","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Arm 1","type":"OTHER"}],"summary":"To evaluate the combined effect of denosumab treatment and discontinuation on cortical thickness at the distal radius by High Resolution-Peripheral Quantitative Computed Tomography (HR-pQCT). Participants randomized to either denosumab or placebo in the 20050179 (NCT00293813) study who completed that study (ie, attended an end of study visit) can be included in this study. At least 12 months should have elapsed since the patient's 20050179 end of study visit.","primaryOutcome":{"measure":"Percent Change From the Parent Study Baseline in Cortical Thickness at the Distal Radius by HR-pQCT","timeFrame":"Baseline of Study 20050179 and Day 1 of this study. Study 20050179 duration was up to 12 months and the median time since completion of Study 20050179 was 32 months.","effectByArm":[{"arm":"Previous Placebo Treatment Group","deltaMin":-5.5,"sd":null},{"arm":"Previous Denosumab Treatment Group","deltaMin":-1.8,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0766"}]},"eligibility":{"minAge":null,"sex":"FEMALE","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":14},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":["http://www.amgentrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":39},"commonTop":[]}}